CartilaGen
company
About
CartilaGen is a startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Health Care
- Founded date
- Sep 8, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CartilaGen is a biotechnology startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
CartilaGen has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Feb 23, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 23, 2021 | Grant | — | 1 |
Iowa G2M Accelerator
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
CartilaGen is funded by 1 investors.
Iowa G2M Accelerator
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Iowa G2M Accelerator
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
